Physician

Michael F Morrow, MD

According to 2025 Medicare claims, Michael Morrow, MD (NPI: 1922027515) practices cardiology in the Panama City-Panama City Beach, FL market, with the plurality of this provider's patient population coming from Bay, FL. This provider's primary affiliated billing organization is ECONFINA CARDIOLOGY GROUP, PA (NPI: 1609801257; TIN: 59-2005970) and primary practice location at 32405-3359.

Morrow's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,652 traditional Medicare patients, billed 8,411 HCPCS/CPT codes, and received $897,386 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,004 prescription claims across 840 beneficiaries totaling $1,133,653 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 20 claims. Open Payments data shows 38 records totaling $901. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $707,711 and ending at $897,386. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $146,315 to $1,133,653. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	4,357	11,046	$707,711
2016	4,379	10,842	$651,964
2017	4,559	11,014	$646,169
2018	3,540	7,464	$434,720
2019	2,269	6,025	$421,216
2020	2,913	8,729	$633,069
2021	2,640	8,571	$893,767
2022	2,540	8,567	$922,885
2023	2,347	7,452	$718,015
2024	2,652	8,411	$897,386

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	532	2,554	$146,315
2016	529	2,686	$205,034
2017	544	2,759	$268,588
2018	535	2,790	$333,941
2019	496	2,639	$373,274
2020	680	3,438	$515,120
2021	703	3,939	$744,968
2022	700	3,822	$877,745
2023	672	3,260	$860,064
2024	840	4,004	$1,133,653

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	14	$30,102
2018	N/R	14	$24,892
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	20	$853
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,444	1,761	$96
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	632	640	$95
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	357	634	$63
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	304	305	$52
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,179	1,244	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	502	30,481	$574,845
Entresto	Sacubitril/Valsartan	178	10,312	$224,557
Xarelto	Rivaroxaban	110	6,779	$125,095
Farxiga	Dapagliflozin Propanediol	29	2,070	$36,421
Jardiance	Empagliflozin	19	1,270	$22,465

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$901	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael F. Morrow, MD?

Tedicare shows public-source Medicare data for Michael F. Morrow, MD (NPI 1922027515), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael F. Morrow, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael F. Morrow, MD?

Michael F. Morrow, MD is linked to ECONFINA CARDIOLOGY GROUP, PA (billing NPI 1609801257) in the available physician profile data.

Does Michael F. Morrow, MD have Open Payments data?

Michael F. Morrow, MD has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.